GlassScriptPhysician profile
Britton Beatrous
NPI 1003309493
$2,022.21
in general payments reported to CMS, 2019-2025
13 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $62.27 · 2023: $1,257 · 2024: $269 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331 · Travel and Lodging: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.69 |
| Travel and Lodging | $629.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,097.87 | 2023-2025 | Inspire |
| Genzyme Corporation | $189.20 | 2023-2025 | |
| Stryker Corporation | $159.12 | 2022-2025 | Na, Vsp System, Vsp Cranial, Xpress Loprofile |
| Regeneron Healthcare Solutions, INC. | $158.90 | 2023-2025 | Dupixent |
| Medtronic, INC. | $125.17 | 2023 | Stealthstation S8 Platform |
| Integra Lifesciences Corporation | $80.59 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $42.77 | 2023 | Grafix Pl, Stravix Pl |
| Acera Surgical, INC. | $42.70 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $41.63 | 2023 | Traumaone |
| Glaxosmithkline, LLC. | $37.39 | 2025 | Nucala |
| Hikma Pharmaceuticals USA | $16.68 | 2024 | Ryaltris |
| Paratek Pharmaceuticals, INC. | $15.48 | 2025 | Xhance |
| Itamar Medical INC | $14.71 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britton Beatrous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.